CN Patent

CN110913862B — 一种局部给药的药物组合物及其制备方法

Assigned to Jiangsu Hengrui Medicine Co Ltd · Expires 2022-12-30 · 3y expired

What this patent protects

本发明涉及一种局部给药的药物组合物及其制备方法。具体而言，本发明涉及一种含有(3aR,5s,6aS)‑N‑(3‑甲氧基‑1,2,4‑噻二唑‑5‑基)‑5‑(甲基(7H‑吡咯并[2,3‑d]嘧啶‑4‑基)氨基)六氢环戊并[c]吡咯‑2(1H)‑甲酰胺或其可药用盐，和二乙二醇单乙醚的药物组合物。

USPTO Abstract

本发明涉及一种局部给药的药物组合物及其制备方法。具体而言，本发明涉及一种含有(3aR,5s,6aS)‑N‑(3‑甲氧基‑1,2,4‑噻二唑‑5‑基)‑5‑(甲基(7H‑吡咯并[2,3‑d]嘧啶‑4‑基)氨基)六氢环戊并[c]吡咯‑2(1H)‑甲酰胺或其可药用盐，和二乙二醇单乙醚的药物组合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN110913862B
Jurisdiction
CN
Classification
—
Expires
2022-12-30
Drug substance claim
No
Drug product claim
No
Assignee
Jiangsu Hengrui Medicine Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.